Medical equipment maker Opto Circuits (India) has reported a consolidated net profit of Rs 121.05 crore for the second quarter ended September 30, 2011, on the back of robust sales in the healthcare segment.
The company had posted a consolidated net profit of Rs 77.37 crore for the quarter ended September 30, 2010, it said.
Consolidated net sales stood at Rs 562.04 crore during the quarter under review against Rs 331.37 crore in the same period last fiscal.
“Consolidated results for prior period do not include the revenues of Cardiac Science Corp and are hence not comparable,” it added.
Opto Circuits had acquired cardiology device maker Cardiac Science Corporation for about $85 million (nearly Rs 375 crore) last year.
“Our strategic initiatives, focus on emerging markets, as well as cross-selling due to successful integration of our US businesses, has paid off and is reflected in our sales growth,” Opto Circuits India CMD, Mr Vinod Ramnani, said in a statement.
During the quarter, Cardiac Science Corporation entered into an exclusive distribution agreement with Omron Healthcare Co Ltd to distribute its Omron Automated External Defibrillator Powerheart G3 HDF — 3000 device in Japan, it added.
Meanwhile, the shares of Opto Circuits were being quoted at Rs 255 apiece in the morning trade on the BSE today, up 1.82 per cent from their previous close.